Take a look inside this month's issue of Contemporary OB/GYN.
Three months after copper intrauterine device (IUD) insertion, nearly 1/3 of women were diagnosed with vulvovaginal candidiasis, compared to nearly 25% of women who received a hormonal IUD, according to a prospective study published in the journal Cellular and Molecular Biology.
Not only for football and safety but also for productivity and efficiency.
Laparoscopy remains the gold standard for diagnosis and treatment of the disease.
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Although leadership in our post-pandemic climate is probably no more challenging than at any other time, it certainly feels that way.
Stay tuned for more articles as they go live!
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More